1型糖尿病患者腹部脂肪与蛋白尿发生及进展的关系 - Suppr

Suppr

超能文献

Relationship Between Abdominal Fatness and Onset and Progression of Albuminuria in Type 1 Diabetes.

作者信息

Parente Erika B, Mutter Stefan, Thorn Lena M, Harjutsalo Valma, Groop Per-Henrik

机构信息

1Folkhälsan Institute of Genetics, Folkhälsan Research Center, Helsinki, Finland.

2Department of Nephrology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.

出版信息

Diabetes Care. 2023 Mar 1;46(3):e81-e82. doi: 10.2337/dc22-1935.

DOI:10.2337/dc22-1935

PMID:36701210

Abstract

摘要

相似文献

Relationship Between Abdominal Fatness and Onset and Progression of Albuminuria in Type 1 Diabetes.

Diabetes Care. 2023 Mar 1;46(3):e81-e82. doi: 10.2337/dc22-1935.

Comments on 'in patients with type 1 diabetes and new-onset microalbuminuria the development of advanced chronic kidney disease may not require progression to proteinuria'.

Kidney Int. 2010 Nov;78(10):1049; author reply 1049. doi: 10.1038/ki.2010.300.

Progression of Diabetic Kidney Disease in the Absence of Albuminuria.

Diabetes Care. 2019 Oct;42(10):1842-1844. doi: 10.2337/dci19-0030.

Eicosapentaenoic and Docosahexaenoic Acids Attenuate Progression of Albuminuria in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease.

J Am Heart Assoc. 2017 Jul 14;6(7):e004740. doi: 10.1161/JAHA.116.004740.

Microalbuminuria, blood pressure and diabetic renal disease: origin and development of ideas.

Diabetologia. 1999 Mar;42(3):263-85. doi: 10.1007/s001250051151.

[Albuminuria in the diabetic patient: practical management].

Praxis (Bern 1994). 2013 Oct 2;102(20):1229-35. doi: 10.1024/1661-8157/a001429.

Morbidity and mortality in young-onset type 2 diabetes in comparison to type 1 diabetes: where are we now?

Curr Diab Rep. 2015 Jan;15(1):566. doi: 10.1007/s11892-014-0566-1.

Diabetic kidney disease with and without albuminuria.

Curr Opin Nephrol Hypertens. 2011 May;20(3):246-57. doi: 10.1097/MNH.0b013e3283456546.

[Microalbuminuria in diabetic patients].

Duodecim. 1995;111(15):1463-9.

Clinical predictive factors in diabetic kidney disease progression.

J Diabetes Investig. 2017 Jan;8(1):6-18. doi: 10.1111/jdi.12533. Epub 2016 Jun 8.

引用本文的文献

Beyond overweight, visceral adiposity is associated with estimation of cardiovascular risk in patients living with type 1 diabetes: findings from the SFDT1 cohort.

Cardiovasc Diabetol. 2025 Jun 14;24(1):256. doi: 10.1186/s12933-025-02789-3.

Relationship between sRAGE and obesity in individuals with type 1 diabetes during a median follow-up of 6.3 years.

Diabetologia. 2025 Apr 29. doi: 10.1007/s00125-025-06440-4.

Lessons learned from the FinnDiane Study: Epidemiology and metabolic risk factors for diabetic kidney disease in type 1 diabetes.

Diabet Med. 2025 Feb;42(2):e15431. doi: 10.1111/dme.15431. Epub 2024 Sep 5.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Relationship Between Abdominal Fatness and Onset and Progression of Albuminuria in Type 1 Diabetes.

Diabetes Care. 2023 Mar 1;46(3):e81-e82. doi: 10.2337/dc22-1935.

Comments on 'in patients with type 1 diabetes and new-onset microalbuminuria the development of advanced chronic kidney disease may not require progression to proteinuria'.

Kidney Int. 2010 Nov;78(10):1049; author reply 1049. doi: 10.1038/ki.2010.300.

Progression of Diabetic Kidney Disease in the Absence of Albuminuria.

Diabetes Care. 2019 Oct;42(10):1842-1844. doi: 10.2337/dci19-0030.

Eicosapentaenoic and Docosahexaenoic Acids Attenuate Progression of Albuminuria in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease.

J Am Heart Assoc. 2017 Jul 14;6(7):e004740. doi: 10.1161/JAHA.116.004740.

Microalbuminuria, blood pressure and diabetic renal disease: origin and development of ideas.

Diabetologia. 1999 Mar;42(3):263-85. doi: 10.1007/s001250051151.

[Albuminuria in the diabetic patient: practical management].

Praxis (Bern 1994). 2013 Oct 2;102(20):1229-35. doi: 10.1024/1661-8157/a001429.

Morbidity and mortality in young-onset type 2 diabetes in comparison to type 1 diabetes: where are we now?

Curr Diab Rep. 2015 Jan;15(1):566. doi: 10.1007/s11892-014-0566-1.

Diabetic kidney disease with and without albuminuria.

Curr Opin Nephrol Hypertens. 2011 May;20(3):246-57. doi: 10.1097/MNH.0b013e3283456546.

[Microalbuminuria in diabetic patients].

Duodecim. 1995;111(15):1463-9.

Clinical predictive factors in diabetic kidney disease progression.

J Diabetes Investig. 2017 Jan;8(1):6-18. doi: 10.1111/jdi.12533. Epub 2016 Jun 8.

引用本文的文献

Beyond overweight, visceral adiposity is associated with estimation of cardiovascular risk in patients living with type 1 diabetes: findings from the SFDT1 cohort.

Cardiovasc Diabetol. 2025 Jun 14;24(1):256. doi: 10.1186/s12933-025-02789-3.

Relationship between sRAGE and obesity in individuals with type 1 diabetes during a median follow-up of 6.3 years.

Diabetologia. 2025 Apr 29. doi: 10.1007/s00125-025-06440-4.

Lessons learned from the FinnDiane Study: Epidemiology and metabolic risk factors for diabetic kidney disease in type 1 diabetes.

Diabet Med. 2025 Feb;42(2):e15431. doi: 10.1111/dme.15431. Epub 2024 Sep 5.

Relationship Between Abdominal Fatness and Onset and Progression of Albuminuria in Type 1 Diabetes.

作者信息

Parente Erika B, Mutter Stefan, Thorn Lena M, Harjutsalo Valma, Groop Per-Henrik

机构信息

1Folkhälsan Institute of Genetics, Folkhälsan Research Center, Helsinki, Finland.

2Department of Nephrology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.

出版信息

Diabetes Care. 2023 Mar 1;46(3):e81-e82. doi: 10.2337/dc22-1935.

DOI:10.2337/dc22-1935

PMID:36701210

Abstract

摘要